More than 500,000 people die from breast cancer annually. An innovative system under development by U.S.-based Marvel Medtech offers a completely new approach to defeating this vicious cancer. The company’s robotic intervention guidance system will enable the use of cryotherapy (extreme cold in medical therapy) to target dangerous tiny breast cancer tumors. Transforming the MRI from a diagnostic-only imaging modality into a practical interventional tool, the solution finds tumors during breast MRI scans and immediately destroys them. The scanner accessory will be vital for early elimination, removing the need for future expensive and invasive biopsy and other surgical procedures. This breakthrough will save lives, dramatically improve patient care and save billions of dollars in healthcare costs. Marvel Medtech requires a probe with very complex geometry. Moreover, the probe must be made of a material that does not interfere with the magnetic field of the MRI, thus zirconia is used. The only way to manufacture this ceramic probe is to use additive manufacturing (AM) and, more specifically, XJet’s technology. This presentation will highlight Marvel Medtech’s unique new technology, properties of the zirconia additively manufactured element and implications for additional applications within medical device and other industries.
- Ceramic AM empowers innovation – enabling the development of completely new parts and going way beyond mere replacement of traditional production methods for efficiency purposes – to positively impact industries
- By making cost of complexity marginal, NPJ produces parts that no other technology before it could manufacture – enabling efficient manufacturing of complex, smooth and accurate parts